T3 AMZ and Cartiform® Viable Osteochondral Allograft with 1-Year Follow-Up

Jeffrey A. Macalena, MD, (Minneapolis, MN) presents a case with 1‐year follow‐up that included a T3 AMZ procedure and a Cartiform^®* viable osteochondral allograft implant to the patella.

*Cartiform is a registered trademark of Osiris Therapeutics, Inc.